Study title: A multicenter, comparative trial of cefprozil (20 mg/kg/day) versus penicillin VK (45 mg/kg/day) in the treatment of mild to moderate pharyngitis and tonsillitis (final report study AI414-105 - pediatric).
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Otorhinolaryngologic Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CEFPROZIL | |||||
| ATC code: | |||||
| Document link: Protocol ai414-105 Cefprozil.pdf | |||||
| Document date: 2011-09-21 | |||||
| Study number: AI414-105 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |